readthroughSign in
CompanySTOKNasdaqBedford, MA

Stoke Therapeutics, Inc

Stoke Therapeutics develops antisense oligonucleotides using its TANGO platform to restore protein expression in haploinsufficiency disorders.

SCHEDULE 13G/ANov 16Latest SEC filing
Oct 27Latest story